Luxembourg hospitals order Sectra MicroDose Mammography system

NewsGuard 100/100 Score

Women in Luxembourg will soon be benefiting from low-dose mammography. Three hospitals in Luxembourg have ordered Sectra MicroDose Mammography after evaluating experiences from other European countries.

At Centre Hospitalier du Luxembourg, Zitha Klinik Luxemburg and Hospital St. Louis Ettelbruck, women participating in the national screening program will now be offered mammography at the lowest possible dose.

The national breast screening program in Luxembourg, established in 1992, covers all women aged 50 to 69 and has a participation rate of 64%.

“Care quality awareness is increasing among our customers, and the Luxembourg screening program is well-known for its high standards of mammography, which makes this a great reference,” says Peter Osinga, Managing Director Sectra Benelux.

Safe and effective mammography screening With superior image quality, Sectra’s mammography system, Sectra MicroDose Mammography, generates by far the lowest dose of radiation among all of the systems offered on the market. Combined with good ergonomics and a well-conceived workflow, the low dose enables radiographers and radiologists to work more efficiently and safely. At the same time, the radiation to which the women are exposed is minimized to the lowest conceivable level. Sectra MicroDose Mammography is based on a unique detector technology that counts each X-ray photon. This is the X-ray technology of the future.

Source:

Sectra Group

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Identifying social determinants influencing breast cancer screening in the U.S.